Article

Survey finds many Americans frustrated by blurry vision

According to a survey commissioned by Allergan, an AbbVie company, 65% of respondents said they were not prepared to have their vision worsen as they aged.

From texting challenges to misplaced reading glasses, the impact of age-related blurry near vision on patients' daily life can be pervasive.

Despite the high prevalence of vision issues like presbyopia, these challenges can still come as a surprise to patients who develop presbyopia.

In fact, according to a recent survey commissioned by Allergan, an AbbVie company, of 1000 adults ages 40 to 55 who reported having near vision issues, 65% of survey respondents said that they were not prepared to have their eyesight worsen as they got older, and a quarter admitted they were in denial that their near vision was getting worse.

“While most people have not heard of the medical term for age-related blurry near vision, presbyopia is a natural part of aging and affects approximately 128 million adults in the U.S.,” said optometrist Selina McGee, OD, fellow of the American Academy of Optometry. “The survey results reinforce what I hear from patients with near vision issues in my practice every day – that these challenges are increasingly frustrating, and impact their daily lives, especially when they are looking at their cell phones, reading, or trying to see a menu in a dimly lit restaurant.”

As the pandemic increased the prevalence of Zoom calls and virtual gatherings, 84% of survey respondents reported that it was more frustrating to have blurry near vision when trying to read than having a video call freeze.

There are options available to manage near vision issues, but they can come with challenges of their own.

More than half of those surveyed with reading glasses (51%) admitted they lose or misplace them at least once a week; and over a quarter (26%) said they lose them daily.

Moreover, for many adults, presbyopia and blurry near vision can impact the activities they enjoy most.

In fact, half of survey respondents admitted they decreased or gave up on a hobby because they could no longer see well up close.

Patientes also can be invited to visit BlurryNearVision.com, a website from Allergan that offers information on presbyopia.

The site features an interactive component that shows how people see text up close when they have presbyopia and a quiz to uncover how the condition could be affecting their daily lives.

Visitors can use these tools as a starting point when talking to their ophthalmologist or eyecare professional about their symptoms.

The online Blurry Near Vision survey, commissioned by Allergan and conducted by Wakefield Research, was fielded from Aug. 2–9, to 1000 nationally representative U.S. adults ages 40 – 55 who reported having near vision issues.

It was not confirmed whether the respondents were diagnosed with presbyopia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.